Rosebud Biosciences

Rosebud Biosciences YC 지원서

Winter 2022Active

Rosebud Biosciences은(는) Winter 2022 배치에서 Healthcare 회사로 Y Combinator를 거쳤습니다. 아래에는 회사의 사업 내용, 창립자, 그리고 실제 YC 양식에 맞춰 재구성한 YC 지원서가 있습니다.

YC 배치
Winter 2022
산업
HealthcareDrug Discovery and Delivery
팀 규모
3
상태
Active
출시됨
2022

창업자

  • Kitch Wilson
    Kitch WilsonFounder
  • Evan Lyall
    Evan LyallFounder

Rosebud Biosciences의 사업 내용

Rosebud Biosciences accelerates drug development by screening drugs against organoids (micro-organs) that have the same gene mutations as the patients. We partner with therapeutics companies to screen their drugs, and we perform our own drug discovery for rare diseases that have no existing treatments. Our organoids are also fetal-like and enable discovery of novel drug targets for pediatric diseases. This technology was validated at Stanford, published in a prestigious journal, and has already led to the discovery of a drug target in a pediatric heart disease that could not have been found using traditional disease models.

Rosebud Biosciences의 YC 지원서, 재구성됨

Y Combinator 지원

Rosebud Biosciences, Winter 2022 기수. 공개 데이터를 기반으로 작성된 실제 지원 질문.

  1. Founders2
  2. Company7
  3. Progress7
  4. Idea4
  5. Equity3
  6. Curious2
  7. Batch Preference1

Company

Company name

Rosebud Biosciences

Describe what your company does in 50 characters or less.

Growing micro-organs to find new drugs

What is your company going to make? Please describe your product and what it does or will do.

We grow organoids with the patients' exact gene mutations to test drugs directly on tissue models that behave like fetal organs. Our platform lets us screen drugs for rare diseases, especially pediatric conditions without treatments. It helps partners find drug candidates faster by using more accurate disease models than standard cell lines or animal models.

Where do you live now, and where would the company be based after YC?

We're based in San Francisco and San Carlos, CA. After YC, we'll stay in the Bay Area to stay close to collaborators and biotech talent.

Explain your decision regarding location.

We want to be near key research institutions and pharma partners, and both of us are already based in the Bay Area. It's where organoid research and biotech venture capital mix best.

전체 지원서에서 21개의 추가 답변

Founders, Progress, Idea, Equity, Curious, Batch Preference는 전체 버전에 있습니다. 무료 계정을 만들어 YC Insights에서 모든 YC 배치 옆에 열어보세요.

자주 묻는 질문

Rosebud Biosciences의 실제 YC 지원서인가요?

아닙니다. Y Combinator는 제출된 지원서를 비공개로 유지합니다. 이것은 재구성된 것입니다. 실제 YC 양식 질문에 Rosebud Biosciences의 공개 데이터(출시 노트, 창업자 배경, 제품 설명)를 기반으로 답변했습니다. Rosebud Biosciences과 같은 회사가 YC에 어떻게 자신을 소개하는지 보여주며, 그들이 제출한 텍스트는 아닙니다.

Rosebud Biosciences은(는) 어떤 YC 배치에 있었나요?

Rosebud Biosciences은(는) Y Combinator Winter 2022 배치에 참여했습니다.

Rosebud Biosciences은(는) 누가 설립했나요?

Rosebud Biosciences은(는) Kitch Wilson, Evan Lyall(이)가 설립했습니다.

Rosebud Biosciences은(는) 무엇을 하나요?

Growing micro-organs to find new drugs

전체 재구성된 지원서를 어떻게 읽나요?

무료 Round Funded 계정을 만드세요. Rosebud Biosciences의 전체 26개 질문 버전 지원서와 모든 YC 배치 지원서는 YC Insights에서 확인할 수 있습니다.

Rosebud Biosciences과(와) 같은 다른 YC 스타트업